Showing results (151-160 of 199) with videos related to
Sort By:
Pageof 20
Journal of Chemical Theory and Computation|December 9, 2015
GW100: Benchmarking G0W0 for Molecular SystemsMichiel J van Setten, Fabio Caruso, Sahar Sharifzadeh, et al.Journal of Magnetic Resonance Imaging : JMRI|May 25, 2021
Fully Automated MR Detection and Segmentation of Brain Metastases in Non-small Cell Lung Cancer Using Deep LearningStephanie T Jünger, Ulrike Cornelia Isabel Hoyer, Diana Schaufler, et al.NPJ Precision Oncology|June 7, 2018
ALKG1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumorSebastian Y F Michels, Andreas H Scheel, Thomas Wündisch, et al.Oncoimmunology|July 29, 2016
PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterationsAndreas H Scheel, Sascha Ansén, Anne M Schultheis, et al.Plos One|May 17, 2011
Benchmarking of mutation diagnostics in clinical lung cancer specimensSilvia Querings, Janine Altmüller, Sascha Ansén, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung CancersJulia Rotow, Jyoti D Patel, Matthew P Hanley, et al.JTO Clinical and Research Reports|March 12, 2026
MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET InhibitionRichard Riedel, Lea Ruge, Malte Verheyen, et al.European Journal of Cancer (Oxford, England : 1990)|June 28, 2024
Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutationsAnna Kron, Matthias Scheffler, Marcel Wiesweg, et al.Lung Cancer (Amsterdam, Netherlands)|August 14, 2023
Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patientsMoritz Glaser, Anna Rasokat, Darinka Prang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responsesLea Ruge, Felix John, Malte Verheyen, et al.Pageof 20